PF4 and COVID-19: The lung autopsies of COVID-19 patients showed upregulated platelet expression of PF4 (CXCL4), which promotes blood coagulation and activates the NF-κB signaling pathway in ECs, acting as a potential agent of both thrombosis and inflammation [4,103].